Omri Amirav Drory

ImmuneBridge is developing allogeneic immunotherapies for cancer.

Raised $12,000,000.00 from Gaingels, Insight Partners, M Ventures, One Way Ventures, Pioneer Fund, Healthspan Capital and Quiet Capital.

TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.

Raised $6,500,000.00 from Alexandria Venture Investments, 2048 Ventures, NFX and GC&H Investments.

ZipBio develops next-gen gene therapies using machine learning, protein engineering, and molecular materials.

Raised $4,000,000.00 from MoreVC and NFX.

Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services.

Raised $14,200,000.00 from NFX and Global Health Investment Corporation.

Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.

Raised $27,781,502.00 from NFX, FundersClub, BoxOne Ventures, Two Bear Capital, Y Combinator Continuity Fund, Rolling Bay Ventures and WRF Capital.